IMPROVED METHOD FOR COMPARATIVE EVALUATION OF ALDOSTERONE ANTAGONISTS IN HEALTHY MAN

被引：12

作者：

CASALSSTENZEL, J

SCHMALBACH, J

LOSERT, W

机构：

[1] SCHERING AG, DEPT GEN PHARMACOL, FORSCHUNGSLAB, D-1000 BERLIN 65, FED REP GER

[2] KRANKENHAUS PORZ, KOLN, FED REP GER

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1977年 / 12卷 / 04期

关键词：

D O I：

10.1007/BF00607423

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：247 / 255

页数：9

共 32 条

[11]

HOFMANN LM, 1975, J PHARMACOL EXP THER, V194, P450

[12] TUBULARE WIRKUNGEN + RENALE ELIMINATION VON SPIROLACTONEN [J].

HOLLMANN, G ;

WERNER, C ;

SENFT, G .

NAUNYN-SCHMIEDEBERGS ARCHIV FUR EXPERIMENTELLE PATHOLOGIE UND PHARMAKOLOGI, 1964, 247 (04) :419-&

[13]

KAGAWA CM, 1964, P SOC EXP BIOL MED, V115, P837

[14]

KARIM A, 1976, CLIN PHARMACOL THER, V19, P170

[15] ISOLATION AND IDENTIFICATION OF NOVEL SULFUR-CONTAINING METABOLITES OF SPIRONOLACTONE (ALDACTONE-R) [J].

KARIM, A ;

BROWN, EA .

STEROIDS, 1972, 20 (01) :41-&

[16]

KARIM A, 1976, CLIN PHARMACOL THER, V19, P158

[17] PHARMACOKINETIC AND METABOLIC FATE OF POTASSIUM CANRENOATE (SC-14266) IN MAN [J].

KARIM, A ;

RANNEY, RE ;

MAIBACH, HI .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (05) :708-&

[18]

LEVIN DM, 1965, CIRCULATION, V32, P135

[19]

MARX P, 1966, THESIS U BERLIN

[20] ALDOSTERONE - CURRENT CONCEPTS [J].

MORRIS, DJ ;

DAVIS, RP .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1974, 23 (05) :473-494

← 1 2 3 4 →